FDA Approved: ARFORMOTEROL TARTRATE INHALATION — Original Application (Slate Run Pharmaceuticals)

View source ↗

Summary

FDA approved Slate Run Pharmaceuticals' ARFORMOTEROL TARTRATE INHALATION for the maintenance treatment of chronic obstructive pulmonary disease; this represents…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Arformoterol tartrate inhalation (arformoterol tartrate inhalation)

Snippet

ORIG AP for ARFORMOTEROL TARTRATE INHALATION (ARFORMOTEROL TARTRATE INHALATION)